XML 68 R51.htm IDEA: XBRL DOCUMENT v3.25.0.1

Earnings Per Share of Common Stock (Tables)

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the reconciliations of the numerators and denominators of the Company’s basic and diluted earnings (loss) per share calculations for the years ended December 31, 2024, 2023 and 2022.

		Year Ended December 31,
		2024				2023				2022
Numerator:
Net income (loss) attributable to Chemours		$	86			$	(238	)		$	578
Denominator:
Weighted-average number of common shares outstanding - basic			149,494,462				148,912,397				155,359,361
Dilutive effect of the Company’s employee compensation plans (1)			677,827				—				2,943,646
Weighted-average number of common shares outstanding - diluted			150,172,289				148,912,397				158,303,007
Basic earnings (loss) per share of common stock (2)		$	0.58			$	(1.60	)		$	3.72
Diluted earnings (loss) per share of common stock (1) (2)			0.57				(1.60	)			3.65

(1)In periods where the Company incurs a net loss, the impact of potentially dilutive securities is excluded from the calculation of EPS, as their inclusion would have an anti-dilutive effect. As such, with respect to the measure of diluted EPS, the impact of 1,584,958 potentially dilutive securities is excluded from the calculation for the year ended December 31, 2023.

(2)Figures may not recalculate exactly due to rounding. Basic and diluted earnings (loss) per share are calculated based on unrounded numbers.

Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

The following table sets forth the average number of stock options and performance stock options that were out of the money and, therefore, were not included in the Company’s diluted earnings (loss) per share calculations for the years ended December 31, 2024, 2023 and 2022.

		Year Ended December 31,
		2024				2023				2022
Average number of stock options			2,246,602				1,444,099				1,077,922

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration